Item 8.01 Other Events. On August 20, 2026, the Board of Directors of Plexus Corp. (the “Company”) approved a new share repurchase program that authorizes the Company to repurchase up to $100.0 million of its common stock beginning upon expiration of the Company’s current $100.0 million share repurchase program, which shall remain in effect until its expiration.…
Filed Aug 24, 2026Accepted Aug 24, 2026, 4:19 PM EDTCIK 785786Accession 0000785786-26-000057
At Plexus, we help create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. From life-saving medical devices and mission-critical aerospace and defense products to industrial automation systems and semiconductor capital equipment, our innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors, supported by a global team of over 20,000 members across our 27 facilities. For more information about Plexus, visit our website at www.plexus.com.
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events.
On August 20, 2026, the Board of Directors of Plexus Corp. (the “Company”) approved a new share repurchase program that authorizes the Company to repurchase up to $100.0 million of its common stock beginning upon expiration of the Company’s current $100.0 million share repurchase program, which shall remain in effect until its expiration. As of August 19, 2026, the remaining balance on the current $100.0 million share repurchase program was $9.6 million. The Company does not have a specific schedule or commitment for the repurchase of the shares and may repurchase shares in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions, legal requirements, financing and other considerations.